David Szekeres

2021

In 2021, David Szekeres earned a total compensation of $1.8M as Executive Vice President, Chief Operating Officer at Heron Therapeutics, a 26% decrease compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$197,760
Option Awards$535,147
Salary$494,400
Stock Awards$583,626
Other$18,498
Total$1,829,431

Szekeres received $583.6K in stock awards, accounting for 32% of the total pay in 2021.

Szekeres also received $197.8K in non-equity incentive plan, $535.1K in option awards, $494.4K in salary and $18.5K in other compensation.

Rankings

In 2021, David Szekeres' compensation ranked 6,385th out of 12,405 executives tracked by ExecPay. In other words, Szekeres earned more than 48.5% of executives.

ClassificationRankingPercentile
All
6,385
out of 12,405
49th
Division
Manufacturing
2,724
out of 5,494
50th
Major group
Chemicals And Allied Products
1,198
out of 2,369
49th
Industry group
Drugs
1,066
out of 2,090
49th
Industry
Pharmaceutical Preparations
769
out of 1,537
50th

Pay ratio

David Szekeres' Pay$1,829,431
Median Employee's Pay$268,692
Pay Ratio

7

to 1

In 2021, the annual total compensation of David Szekeres was $1,829,431.

The annual total compensation of the median employee at Heron Therapeutics was $268,692.

The ratio of David Szekeres' pay to the pay of median employee was therefore 7 to one.

Source: SEC filing on April 25, 2022.

Szekeres' colleagues

We found four more compensation records of executives who worked with David Szekeres at Heron Therapeutics in 2021.

2021

Barry Quart

Heron Therapeutics

Chief Executive Officer

2021

Kimberly Manhard

Heron Therapeutics

Executive Vice President, Drug Development

2021

John Poyhonen

Heron Therapeutics

President and Chief Commercial Officer

2021

Lisa Peraza

Heron Therapeutics

Chief Accounting Officer

News

You may also like